Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Marky1on Mar 30, 2021 9:59pm
364 Views
Post# 32911692

IPO

IPO

The original IPO was was June 18 th 2013....It began trading at the equivalent price of $5.50 (.55$ presplit).  That's almost 8 years of no movement of the SP...Our long voyage is about to break out, IMHO.
The way I see things going...Further partnership deals with pharm companies such as GUD for Latin America, other deals for the USA, Europe, Japan and the rest of the world...Money swelling up our chest...
Final dissolution of ANTIBE Holding Corporation leading to one strong and uncomplicated entity.
By August, 7 months after hiring Dr. Haut, i believe that he will present to the world a huge acquisition deal with Bayer for the entire company. It took him exactly 7 months to ink a deal to sell the company that he was working for ( AskBio) for 4B$ USD
people..hang on to your shares...worth their weight in gold !

Exciting days are coming..


 

<< Previous
Bullboard Posts
Next >>